How should we use anti-CTLA-4 antibodies?

被引：7
|
作者：
Marabelle, Aurelien [1 ,2 ]
Eggermont, Alexander [1 ]
机构：
[1] Gustave Roussy Canc Campus Grand Paris, F-94805 Villejuif, France
[2] INSERM, U1015, F-94805 Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷 / 17期
关键词：
REGULATORY T-CELLS; METASTATIC MELANOMA; IPILIMUMAB;
D O I：
10.1016/j.ejca.2015.09.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2686 / 2688
页数：3
相关论文
共 50 条
  • [1] Therapeutic use of anti-CTLA-4 antibodies
    Blank, Christian U.
    Enk, Alexander
    INTERNATIONAL IMMUNOLOGY, 2015, 27 (01) : 3 - 10
  • [2] Next-generation anti-CTLA-4 antibodies
    Korman, Alan J.
    Engelhardt, John
    Loffredo, John
    Valle, Jose
    Akter, Rahima
    Vuyyuru, Raja
    Bezman, Natalie
    So, Paula
    Graziano, Robert
    Tipton, Kimberly
    West, James
    Irving, Bryan
    Selby, Mark
    CANCER RESEARCH, 2017, 77
  • [3] Update on anti-CTLA-4 antibodies in clinical trials
    Langer, Lee F.
    Clay, Timothy M.
    Morse, Michael A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (08) : 1245 - 1256
  • [4] ATG/TMG immunosuppressive effect is mediated by anti-CTLA-4 antibodies
    Pistillo, MP
    Tazzari, PL
    Bonifazi, F
    Bandini, G
    Kato, T
    Matsui, T
    Nishioka, K
    Conte, R
    Ferrara, GB
    TISSUE ANTIGENS, 2002, 59 : 142 - 142
  • [5] Drug therapy of melanoma: anti-CTLA-4 and anti-PD-1 antibodies
    Robert, Caroline
    Mateus, Christina
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2014, 198 (02): : 297 - 308
  • [6] How Does an Anti-CTLA-4 Antibody Promote Cancer Immunity?
    Liu, Yang
    Zheng, Pan
    TRENDS IN IMMUNOLOGY, 2018, 39 (12) : 953 - 956
  • [7] Interferon in anti-CTLA-4 responses
    David Killock
    Nature Reviews Clinical Oncology, 2016, 13 (11) : 653 - 653
  • [8] Mechanism informs precision: In vivo determinants of response to anti-CTLA-4 antibodies
    Furness, A. J. S.
    Vargas, F. Arce
    Litchfield, K.
    Rosenthal, R.
    Gore, M.
    Larkin, J.
    Turajlic, S.
    Swanton, C.
    Peggs, K.
    Quezada, S.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] The Emerging Toxicity Profiles of Anti-CTLA-4 Antibodies Across Clinical Indications
    Di Giacomo, Anna Maria
    Biagioli, Maurizio
    Maio, Michele
    SEMINARS IN ONCOLOGY, 2010, 37 (05) : 499 - 507
  • [10] Anti-CTLA-4 antibodies A major therapeutic advance in metastatic melanoma treatment
    Robert, Caroline
    Mateus, Christine
    M S-MEDECINE SCIENCES, 2011, 27 (10): : 850 - 858
12345